Information Costs, Policy Uncertainty, and Political Control: Federal Advisory Committees at the FDA

Abstract

The authors investigate how the Food and Drug Administration uses advisory committees in the approval of drugs and medical devices. Such committees may share policy expertise or help legitimize agency positions. Advisory committees also may facilitate political accountability by making decision-making more transparent and by giving certain interests seats at the table.